TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CDXS

Codexis Inc

Healthcare · Biotechnology

1.40$ +3.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow CDXS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-234.9% -566.5%
-19.1% -16.0% -77.1% +10.1% +297.3% -0.1% +30.6% +72.4% -3.2% -50.2% +6.1%
+11.0% +10.7% +25.0% +11.3% -12.0% +11.3% +50.0% +25.3% -31.4% +31.3% -26.5%
-11.3% +9.2% +22.4% +15.8% -6.4% +4.2% +11.6% +50.2%
-150.1% -296.0% -184.4%
+297.0% -25.9% +10.9% +181.0% +34.8% +0.5% +268.9% -39.9% -46.8% -2.6% +3.9%
-127.0% -33.0% +7.8% +204.6% +32.5% +56.8% +272.7% -36.6% -64.2% +1,072.9%
-55.9%
+122.5% -15.9% +9.6% +91.0% -10.7% -55.9% -4.1% +23.4% -72.8%
+0.0% +0.0% +0.0% +36.0% +1.7% -75.2% -100.0% -66.5%
+149.4% -67.8% +78.1% +39.9% +49.8% -95.3% -115.3% +641.1% -53.9%
-173.8% +81.2% +73.8% +55.3% -154.5%
-8,689.5% -2,016.6%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?